Acute Myelomonocytic Leukemia - 190 Studies Found
Completed |
: Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia :
: Other: laboratory biomarker analysis Correlative studies |
Active, not recruiting |
: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia :
|
Completed |
: Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia :
|
Completed |
: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia :
|
Active, not recruiting |
: Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders :
|
Active, not recruiting |
: Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia :
|
Active, not recruiting |
: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant :
|
Completed |
: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase :
|
Completed |
: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia :
|